Abstract Title:

Immunomodulatory activity of curcumin.

Abstract Source:

Immunol Invest. 1999 Sep-Dec;28(5-6):291-303. PMID: 10574627

Abstract Author(s):

S Antony, R Kuttan, G Kuttan

Article Affiliation:

Amala Cancer Research Centre, Amala Nagar, Kerala, India.


Curcumin, an active ingredient present in Curcuma longa, was analysed for the immunomodulatory activity in Balb/c mice. Curcumin administration was found to increase the total WRC count (15,290) significantly on the 12th day Group of animals treated with vehicle alone showed results similar to that of normal animal (10,130 on 12th day). Curcumin increased the circulating antibody titre (512) against SRBC. Curcumin administration increased the plaque forming cells (PFC) in the spleen and the maximum number of PFC was observed on the 6th day (1,130 PFC/10(6) spleen cells) after immunization with SRBC. Rone marrow cellularity (16.9x10(6) cells/femur) and alpha-esterase positive cells (1,622/4000 cells) were also enhanced by Curcumin administration. A significant increase in macrophage phagocytic activity was also observed in Curcumin treated animals (P<0.001). These results indicate the immunostimulatory activity of Curcumin.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.